Formulation and In Vitro Evaluation of Rifampicin Loaded Porous Microspheres

Rifampicin (RIF) is a major component in fixed dose combination therapy for the treatment of tuberculosis. RIF has low solubility and high permeability with high dose and hence it is classified as class II drug in Biopharmaceutical Classification System (BCS). RIF has poor and variable bioavailabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhise, Satish Balakrishna, More, Avinash Bhanudas, Malayandi, Rajkumar
Formato: Texto
Lenguaje:English
Publicado: Österreichische Apotheker-Verlagsgesellschaft 2010
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002794/
https://www.ncbi.nlm.nih.gov/pubmed/21179348
http://dx.doi.org/10.3797/scipharm.0910-09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002794/
https://www.ncbi.nlm.nih.gov/pubmed/21179348
http://dx.doi.org/10.3797/scipharm.0910-09

Ejemplares similares